Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Gutin

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Journal of Cutaneous Pathology|March 3, 2015
Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanomaLoren E Clarke, M B Warf, Darl D Flake, et al.
Human Molecular Genetics|August 9, 2006
TBC1D1 is a candidate for a severe obesity gene and evidence for a gene/gene interaction in obesity predispositionSteven Stone, Victor Abkevich, Deanna L Russell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2022
Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast CancerAnastasia Constantinidou, Yiola Marcou, Michael S Toss, et al.
Cancer|July 6, 2021
Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health InitiativeAllison W Kurian, Elisha Hughes, Timothy Simmons, et al.
British Journal of Cancer|October 25, 2018
Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genesDarren R Hodgson, Brian A Dougherty, Zhongwu Lai, et al.
JCO Precision Oncology|May 26, 2021
Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic TestingElisha Hughes, Placede Tshiaba, Susanne Wagner, et al.
The Lancet. Oncology|February 12, 2011
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective studyJack Cuzick, Gregory P Swanson, Gabrielle Fisher, et al.
Rheumatology (Oxford, England)|December 28, 2018
Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritisJeffrey R Curtis, Darl D Flake, Michael E Weinblatt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancerBryan T J Hennessy, Kirsten M Timms, Mark S Carey, et al.
Human Molecular Genetics|March 28, 2008
Identification of ZNF313/RNF114 as a novel psoriasis susceptibility geneFrancesca Capon, Marie-José Bijlmakers, Natalie Wolf, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Journal of Cutaneous Pathology|March 3, 2015
Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanomaLoren E Clarke, M B Warf, Darl D Flake, et al.
Human Molecular Genetics|August 9, 2006
TBC1D1 is a candidate for a severe obesity gene and evidence for a gene/gene interaction in obesity predispositionSteven Stone, Victor Abkevich, Deanna L Russell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2022
Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast CancerAnastasia Constantinidou, Yiola Marcou, Michael S Toss, et al.
Cancer|July 6, 2021
Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health InitiativeAllison W Kurian, Elisha Hughes, Timothy Simmons, et al.
British Journal of Cancer|October 25, 2018
Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genesDarren R Hodgson, Brian A Dougherty, Zhongwu Lai, et al.
JCO Precision Oncology|May 26, 2021
Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic TestingElisha Hughes, Placede Tshiaba, Susanne Wagner, et al.
The Lancet. Oncology|February 12, 2011
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective studyJack Cuzick, Gregory P Swanson, Gabrielle Fisher, et al.
Rheumatology (Oxford, England)|December 28, 2018
Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritisJeffrey R Curtis, Darl D Flake, Michael E Weinblatt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancerBryan T J Hennessy, Kirsten M Timms, Mark S Carey, et al.
Human Molecular Genetics|March 28, 2008
Identification of ZNF313/RNF114 as a novel psoriasis susceptibility geneFrancesca Capon, Marie-José Bijlmakers, Natalie Wolf, et al.
Pageof 7